Login / Signup

Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index.

Laura J RossDylan HansenSusanna ProudmanZsuzsanna H McMahanAriane L HerrickWendy StevensMurray BaronMandana Nikpournull null
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
We present a novel instrument to quantify the burden of disease activity in SSc. We have employed a rigorous consensus-based process in combination with data-driven methods to develop an instrument that has face, content, and criterion validity. Further work is required to fully validate and confirm the construct and discriminative validity of the SCTC-AI.
Keyphrases
  • clinical trial
  • artificial intelligence
  • clinical practice
  • deep learning